Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRockwood Strat. Regulatory News (RKW)

Share Price Information for Rockwood Strat. (RKW)

Share Price is delayed by 15 minutes
Get Live Data
316.00    3.00 (0.95%)
Bid:
316.00
Ask:
319.00
Spread: 3.00 (0.949%)
Market Cap: £179.20m
RKW Live PriceLast checked at - London Stock Exchange

Intraday Rockwood Strat. Share Chart

Trading Update

2 Oct 2025 07:00

RNS Number : 7978B
Rockwood Strategic PLC
02 October 2025
 

Rockwood Strategic plc ("RKW" or the "Company")

Trading Update

 

Rockwood Strategic plc (LSE: RKW) today provides an update ahead of publication of its unaudited results for the six months ended 30th September 2025 (the "Period").

 

Interim Highlights

-  NAV Total Return performance in the Period of 12.5% to 279.91p per share, which compares to rises in the FTSE Small Cap (ex-ITs) of 12.1% and the FTSE AIM All-Share of 14.8%.

-  Total Shareholder Return in the Period was 11.5%.

-  NAV Total Return performance in the three years to 30th September 2025 of 93.9%, which compares to the FTSE Small Cap (ex-ITs) of 31.2% and the FTSE AIM All-Share of -2.9%. The Total Shareholder Return in this period was 99.7%.

-  The Company's shares traded at an average premium to NAV of 1.6% in the Period and ended the Period at a 0.8% premium.

-  Significant investor demand resulted in the issuance of 9,343,667 new shares in the Period, increasing the share count by 24% and, alongside performance, growing NAV to £134.8m. NAV has now grown 267% in the last three years, building scale and widening our practicable investment universe. Net Cash at Period end was c.£9.8m, 7.3% of NAV.

 

- Twenty-four holdings at period end, with the top ten investments cumulatively representing 59.3% of NAV.

 

- Two new portfolio investments were made during the Period: Treatt Plc has subsequently had a takeover approach at a derisory level. Tribal Group Plc has rapidly risen 53% since our initial purchase. Full details will be provided in the Company's forthcoming Interim Report.

 

- One investment was realised, Galliford Try Plc, generating a 48.2% IRR and 2.4x money multiple. Initially purchased in Q2 2022 our investment thesis has been delivered over three years via a material valuation re-rating of the equity and excellent turnaround of the company's operating performance.

- Top five holding, Vanquis Banking Group Plc, has risen over 100% as financial progress builds and motor finance liability clarity emerged. Filtronic Plc won its largest ever contract from SpaceX.

- Centaur Media Plc reported the successful sales for cash of the MiniMBA, The Lawyer and Marketing Week which, when combined with existing cash, exceeds the market capitalisation at the end of the period. This is a clear current example of the pricing inefficiency in this part of the UK stock market, the value inherent in the portfolio and the nature of available investment opportunities.

 

Richard Staveley, Fund Manager, said:

"Rockwood Strategic continues to demonstrate that amongst widespread doom and gloom, attractive investment returns are possible via our differentiated approach. The spectre of potential tax changes combined with heightened inflation and disruptive US trade policy have been dampening 'animal spirits' which motivate corporate investment and hiring decisions, alongside equity markets. However, our companies tend to be driven by 'self-help' and strategic catalysts of a materiality that outweighs a soggy economic backdrop. Furthermore, we believe all are at a deep discount to intrinsic value. We expect positive progress across the portfolio during the rest of our financial year and an optimist might expect tax clarity, lower inflation and stabilised trade policy to emerge in the near future."

For further information, please contact:

Rockwood Strategic plc

Chairman

 

Noel Lamb

 

020 7264 4444

 

Rockwood Asset Management

Investment Manager

 

 

Christopher Hart

 

020 7640 3200

Singer Capital Markets Advisory LLP

 

 

 

James Maxwell

James Fischer

 

 020 7496 3000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPKBBBPBDKOKK
Date   Source Headline
8th Jul 20244:41 pmRNSNet Asset Value(s)
4th Jul 20247:00 amRNSDirector Declaration
1st Jul 20244:51 pmRNSNet Asset Value(s)
1st Jul 20241:00 pmRNSDividend Declaration
28th Jun 20242:30 pmRNSPosting of Annual Report and Notice of AGM
24th Jun 20244:11 pmRNSNet Asset Value(s)
24th Jun 20247:00 amRNSBlock listing Interim Review
19th Jun 20247:00 amRNSFull Year Results to 31 March 2024
17th Jun 20244:42 pmRNSNet Asset Value(s)
10th Jun 20244:12 pmRNSNet Asset Value(s)
3rd Jun 20244:29 pmRNSNet Asset Value(s)
28th May 20245:11 pmRNSNet Asset Value(s)
21st May 20247:00 amRNSIssue of Equity
20th May 20244:16 pmRNSNet Asset Value(s)
16th May 20247:00 amRNSInvestor Presentation via Investor Meet Company
13th May 20241:58 pmRNSNet Asset Value(s)
7th May 20244:40 pmRNSNet Asset Value(s)
1st May 20246:02 pmRNSNet Asset Value(s)
29th Apr 20243:31 pmRNSNet Asset Value(s)
29th Apr 20247:00 amRNSIssue of Equity
26th Apr 20247:00 amRNSIssue of Equity
24th Apr 20247:00 amRNSIssue of Equity
23rd Apr 20247:00 amRNSIssue of Equity
22nd Apr 20244:33 pmRNSNet Asset Value(s)
15th Apr 20243:55 pmRNSNet Asset Value(s)
10th Apr 20247:01 amRNSDirector/PDMR Shareholding
10th Apr 20247:00 amRNSIssue of Equity
8th Apr 20244:19 pmRNSNet Asset Value(s)
2nd Apr 20246:07 pmRNSNet Asset Value(s)
2nd Apr 20247:00 amRNSIssue of Equity
25th Mar 20243:55 pmRNSNet Asset Value(s)
22nd Mar 20247:00 amRNSIssue of Equity
20th Mar 20247:00 amRNSIssue of Equity
18th Mar 20244:47 pmRNSNet Asset Value(s)
18th Mar 20247:00 amRNSIssue of Equity
15th Mar 20247:00 amRNSIssue of Equity
14th Mar 20247:00 amRNSIssue of Equity
13th Mar 20247:00 amRNSIssue of Equity
11th Mar 20244:12 pmRNSNet Asset Value(s)
7th Mar 20247:00 amRNSIssue of Equity
4th Mar 20242:59 pmRNSNet Asset Value(s)
1st Mar 20244:05 pmRNSNet Asset Value(s)
26th Feb 20243:22 pmRNSNet Asset Value(s)
22nd Feb 20247:00 amRNSIssue of Equity
19th Feb 20243:07 pmRNSNet Asset Value(s)
15th Feb 20247:00 amRNSIssue of Equity, Investment Manager Shareholding
13th Feb 20247:00 amRNSBlock Listing Approval
9th Feb 20247:00 amRNSBlock Listing Application
8th Feb 20247:00 amRNSIssue of Equity and TVR
5th Feb 20242:30 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.